Abstract
There is evidence for two subpopulations among circulating endothelial progenitor cells (EPCs), i.e., CD34+-EPCs and CD14+-EPCs. Prior studies on the relationship between the level of EPCs and coronary artery disease (CAD), either did not distinguish between the two types of EPCs or studied only CD34+-EPCs. We therefore investigated whether the number of circulating CD14+-EPCs correlates with either CAD and/or cardiovascular risk factors. Circulating CD14+-EPCs—as defined by the surface markers CD14+KDR+—were analyzed by flow cytometry in 100 individuals [34 control subjects, 41 patients with stable CAD and 25 patients with acute coronary syndromes (ACS)]. The level of circulating CD14+-EPCs was not significantly different in patients with normal coronary arteries compared to those with stable CAD or ACS. Neither was there any association between the severity of CAD or risk factors and the number of circulating CD14+-EPCs. Thus, the number of circulating CD14+-EPCs was not significantly correlated either with the severity of coronary disease or with cardiovascular risk factors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Diabetes Association (2004) Diagnosis and classification of diabetes mellitus. Diabetes Care 27(Suppl 1):S5–S10 doi:10.2337/diacare.27.2007.S5
Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964–967 doi:10.1126/science.275.5302.964
Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M et al (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221–228
Burger PE, Coetzee S, McKeehan WL, Kan M, Cook P, Fan Y et al (2002) Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells. Blood 100:3527–3535 doi:10.1182/blood.V100.10.3527
Dimmeler S, Zeiher AM (2004) Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis. J Mol Med 82:671–677 doi:10.1007/s00109-004-0580-x
Drexler H, Hornig B (1999) Endothelial dysfunction in human disease. J Mol Cell Cardiol 31:51–60 doi:10.1006/jmcc.1998.0843
Eggermann J, Kliche S, Jarmy J, Hoffmann K, Mayr-Beyrle U, Debatin KM et al (2003) Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood. Cardiovasc Res 58:478–486 doi:10.1016/S0008-6363(03)00252-9
Elsheikh E, Uzunel M, He Z, Holgersson J, Nowak G, Sumitran-Holgersson S (2005) Only a specific subset of human peripheral-blood monocytes has endothelial-like functional capacity. Blood 106:2347–2355 doi:10.1182/blood-2005-04-1407
Fadini GP, Coracina A, Baesso I, Agostini C, Tiengo A, Avogaro A et al (2006) Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke 37:2277–2282 doi:10.1161/01.STR.0000236064.19293.79
Fernandez Pujol B, Lucibello FC, Gehling UM, Lindemann K, Weidner N, Zuzarte ML et al (2000) Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65:287–300 doi:10.1046/j.1432-0436.2000.6550287.x
Friedrich EB, Walenta K, Scharlau J, Nickenig G, Werner N (2006) CD34−/CD133+/VEGFR−2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res 98:e20–e25 doi:10.1161/01.RES.0000205765.28940.93
Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51:606 doi:10.1016/S0002-9149(83)80105-2
George J, Goldstein E, Abashidze S, Deutsch V, Shmilovich H, Finkelstein A et al (2004) Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur Heart J 25:1003–1008 doi:10.1016/j.ehj.2004.03.026
George J, Shmilovich H, Deutsch V, Miller H, Keren G, Roth A (2006) Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Eng 12:331–335 doi:10.1089/ten.2006.12.331
Gulati R, Jevremovic D, Peterson TE, Chatterjee S, Shah V, Vile RG et al (2003) Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 93:1023–1025 doi:10.1161/01.RES.0000105569.77539.21
Güven H, Shepherd RM, Bach RG, Capoccia BJ, Link DC (2006) The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol 48:1579–1587 doi:10.1016/j.jacc.2006.04.101
Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA et al (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593–600 doi:10.1056/NEJMoa022287
Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK et al (2004) Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24:288–293 doi:10.1161/01.ATV.0000114236.77009.06
Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K et al (2004) Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104:2752–2760 doi:10.1182/blood-2004-04-1396
Lin Y, Weisdorf D, Solovey A, Hebbel RP (2000) Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105:71–77 doi:10.1172/JCI8071
Losordo DW, Isner JM, Diaz-Sandoval LJ (2003) Endothelial Recovery. The next target in restenosis prevention. Circulation 107:2635–2637 doi:10.1161/01.CIR.0000071083.31270.C3
Massa RV, Ferrario M, Campanelli R, Ramajoli I, Rosso R, De Ferrari GM et al (2005) Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105:199–206 doi:10.1182/blood-2004-05-1831
Nowak G, Karrar A, Holmen C, Nava S, Uzunel M, Hultenby K et al (2004) Expression of vascular endothelial growth factor receptor-2 or Tie-2 on peripheral blood cells defines functionally competent cell populations capable of reendothelialization. Circulation 110:3699–3707 doi:10.1161/01.CIR.0000143626.16576.51
Rehman J, Li J, Orschell CM, March KL (2003) Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107:1164–1169 doi:10.1161/01.CIR.0000058702.69484.A0
Reyes M, Dudek A, Jahagirdar B, Koodie L, Marku PH, Verfaillie CM (2002) Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109:337–346
Romagnani P, Annunziato F, Liotta F, Lazzeri E, Mazzinghi B, Frosali F et al (2005) CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res 97:314–322 doi:10.1161/01.RES.0000177670.72216.9b
Rubanyi GM (1993) The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 22(Suppl 4):S1–S14 doi:10.1097/00005344-199304000-00002
Sawano A, Iwai S, Sakurai Y, Ito M, Shitara K, Nakahata T et al (2001) Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 97:785–791 doi:10.1182/blood.V97.3.785
Schmeisser A, Garlichs CD, Zhang H, Eskafi S, Graffy C, Ludwig J et al (2001) Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel (R) under angiogenic conditions. Cardiovasc Res 49:671–680 doi:10.1016/S0008-6363(00)00270-4
Schmidt-Lucke C, Rössig L, Fichtlscherer S, Vasa M, Britten M, Kämper U et al (2005) Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111:2981–2987 doi:10.1161/CIRCULATIONAHA.104.504340
Urbich C, Dimmeler S (2004) Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95:343–353 doi:10.1161/01.RES.0000137877.89448.78
Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H et al (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89:E1–E7 doi:10.1161/hh1301.093953
Werner N, Nickenig G (2006) Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med 10:318–332 doi:10.1111/j.1582-4934.2006.tb00402.x
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Hu, T., She, Q., Jiang, Y. et al. Level of CD14+-endothelial progenitor cells is not associated with coronary artery disease or cardiovascular risk factors. AGE 30, 319–326 (2008). https://doi.org/10.1007/s11357-008-9074-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11357-008-9074-z